No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Canaccord Genuity initiated coverage of Beauty Tech Group with a 'buy' rating and 545p target price on Monday, highlighting what it called one of the strongest pureplay beautytechnology platforms globally.
Canaccord Genuity said Beauty Tech's three brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - give it exposure across all four major athome device technologies, positioning it well in a fastgrowing, underpenetrated 9bn to 12bn market.
The Canadian bank pointed to multiple growth drivers, including a multibrand, multitechnology model, inhouse research and development, clinical validation and a global D2C infrastructure.
Canaccord said CurrentBody Skin remains the core engine, but highlighted that ZIIP was set for a stepchange from FY27, and that Tria offered longerterm upside, supported by more than 40 products in development.
The broker also flagged Beauty Tech's strengthened balance sheet, strong cash generation and rapid financial growth - with revenue rising from 50.8m in FY22 to 141m in FY25 - and argued that the shares trade at a material discount to peers despite superior growth and margins.
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.